Cancer genetics

American Journal of Medical Genetics

Volumn 111, Issue 1, 2002, Pages 96-102

  Knudson, Alfred G ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Apoptosis; Cell cycle; Chromosomal translocation; DNA repair genes; Mutational equilibrium; Oncogenes; Penetrance; Phakomatoses; Signal transduction; Somatic mutation; Transcription factors; Tumor suppressor genes

Indexed keywords

APC PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; ONCOPROTEIN; PROTEIN P14; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; WNT PROTEIN;

APOPTOSIS; AUTOSOMAL DOMINANT DISORDER; CANCER GENETICS; CANCER RISK; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; KARYOTYPE; LEUKEMIA; LYMPHOMA; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE; PENETRANCE; PHAKOMATOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL GENETICS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ADOLESCENT; ADULT; FEMALE; GENETIC SELECTION; GENETICS; MALE; MOLECULAR CLONING; MUTATION; NEOPLASM; PHYSIOLOGY;

ADOLESCENT; ADULT; APOPTOSIS; CELL CYCLE; CLONING, MOLECULAR; DNA REPAIR; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMAN; MALE; MUTATION; NEOPLASMS; NEOPLASTIC SYNDROMES, HEREDITARY; NEUROCUTANEOUS SYNDROMES; ONCOGENES; PROTEIN P53; RETINOBLASTOMA PROTEIN; SELECTION (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037157786     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10320     Document Type: Review

References (52)

1. The retinoblastoma protein copurifies with E2F-I, an EIA-regulated inhibitor of the transcription factor E2F
2. Suppression of human colorectal carcinoma cell growth by wild-type p53
3. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
4. Mutator phenotypes in human colorectal carcinoma cell lines
5. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer
6. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
7. The E2F transcription factor is a cellular target for the RB protein
8. Molecular basis of human B cell neoplasia
9. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
10. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias
11. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
12. A genetic model for colorectal tumorigenesis
13. The p53 proto-oncogene can act as a suppressor of transformation
14. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
15. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
16. Abnormal centrosome amplification in the absence of p53
17. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations
18. Mouse models in tumor suppression
19. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity
20. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene
21. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
22. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
23. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
24. Human homolog of patched, a candidate gene for the basal cell nevus syndrome
25. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
26. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
27. Mutation and cancer: Statistical study of retinoblastoma
28. Mutation and human cancer
29. Retinoblastoma: A prototypic hereditary neoplasm
30. Chasing the cancer demon
31. Chromosomal deletion and retinoblastoma
32. T antigen is bound to a host protein in SV40-transformed cells
33. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
34. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
35. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
36. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
37. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
38. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
39. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
40. Mutation of a mutL homolog in hereditary colon cancer
41. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
42. Comparative genomics of the eukaryotes
43. Chromosomal instability and cytoskeletal defects in oral cancer cells
44. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
45. Cancer cell cycles
46. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
47. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
48. National Cancer Institute Workshop Report: The phakomatoses revisited
49. Eye symptoms in phakomatoses
50. Association between an oncogene and an antioncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
51. Molecular thanatopsis: A discourse on the BCL2 family and cell death
52. Trisomy 7-harboring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas